| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |